Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Hong Zhao & Li Song. (2022) TKP, a Serine Protease from Trichosanthes kirilowii, Inhibits Cell Proliferation by Blocking Aerobic Glycolysis in Hepatocellular Carcinoma Cells. Nutrition and Cancer 74:1, pages 333-345.
Read now
Read now
Han Xiao, Qian Cheng, Xinyu Wu, Yishu Tang, Jing Liu & Xin Li. (2019) ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway. Cancer Management and Research 11, pages 8547-8555.
Read now
Read now
Xinyi Zhou, Xue Wu & Baoan Chen. (2019) Sorcin: a novel potential target in therapies of cancers. Cancer Management and Research 11, pages 7327-7336.
Read now
Read now
Wenli Chen, Tao Li, Jian Wang, Long Liang, Dandan Huang, Gaoshu Yan, Ye Tian, Xiaoli Zhang & Wei Zhang. (2019) Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer. Cancer Management and Research 11, pages 8157-8165.
Read now
Read now
Jessica Pahle & Wolfgang Walther. (2016) Vectors and strategies for nonviral cancer gene therapy. Expert Opinion on Biological Therapy 16:4, pages 443-461.
Read now
Read now
Articles from other publishers (25)
Tai-Hsin Tsai, Kuan-Ting Lee & Yi-Chiang Hsu. (2023) JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells. Biomedicines 11:11, pages 2999.
Crossref
Crossref
Priya, Shalini Jaswal, Ghanshyam Das Gupta & Sant Kumar Verma. (2023) A comprehension on synthetic strategies of Aurora kinase A and B inhibitors. Journal of Molecular Structure 1278, pages 134935.
Crossref
Crossref
Nuray Üremiş, Muhammed Mehdi Üremiş, Yılmaz Çiğremiş, Emir Tosun, Ahmet Baysar & Yusuf Türköz. (2022)
Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of
JAK
/
STAT3
,
MAPK
/
ERK
, and
AKT
/
mTOR
signaling pathways in
HepG2
cell line
. Journal of Food Biochemistry 46:10.
Crossref
Crossref
Hanieh Fahmideh, Hooriyeh Shapourian, Rasol Moltafeti, Chanour Tavakol, Razieh Forghaniesfidvajani, Hamidreza Zalpoor & Mohsen Nabi-Afjadi. (2022) The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment. Oxidative Medicine and Cellular Longevity 2022, pages 1-17.
Crossref
Crossref
Qingfa Tang, Haihong Cao, Ni Tong, Yuanliang Liu, Wanyu Wang, Yuheng Zou, Lanyang Xu, Zhiyun Zeng, Wei Xu, Zhixin Yin, Wenjuan Ma & Qirui Wang. (2022) Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway. Phytomedicine 99, pages 154016.
Crossref
Crossref
Nidhi Varshney, Annu Rani, Dharmendra Kashyap, Deeksha Tiwari & Hem Chandra Jha. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
261
322
.
Tathagata Pradhan, Ojasvi Gupta, Gurpreet Singh & Vikramdeep Monga. (2021) Aurora kinase inhibitors as potential anticancer agents: Recent advances. European Journal of Medicinal Chemistry 221, pages 113495.
Crossref
Crossref
Ying Kao, Wen-Chiuan Tsai, Ssu-Han Chen, Shao-Yuan Hsu, Li-Chun Huang, Chih-Ju Chang, Shih-Ming Huang & Dueng-Yuan Hueng. (2021) Shugoshin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas. Scientific Reports 11:1.
Crossref
Crossref
Xiukun Lin & Ammad Ahmad Farooqi. (2021) Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways. Seminars in Cancer Biology 73, pages 302-309.
Crossref
Crossref
Alexander Ou, Martina Ott, Dexing Fang & Amy Heimberger. (2021) The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma. Cancers 13:3, pages 437.
Crossref
Crossref
Taciani de Almeida Magalhães, Graziella Ribeiro de Sousa, Gustavo Alencastro Veiga Cruzeiro, Luiz Gonzaga Tone, Elvis Terci Valera & Kleiton Silva Borges. (2020) The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology. Journal of Molecular Medicine 98:4, pages 495-512.
Crossref
Crossref
Hang Cao, Xuejun Li, Feiyifan Wang, Yueqi Zhang, Yi Xiong & Qi Yang. (2020) Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems. Current Medicinal Chemistry 27:4, pages 599-629.
Crossref
Crossref
Hualei Bu, Yingwei Li, Chengjuan Jin, Hongfeng Yu, Xiangxiang Wang, Jingying Chen, Yu Wang, Yana Ma, Youzhong Zhang & Beihua Kong. (2020) Overexpression of PRC1 indicates a poor prognosis in ovarian cancer. International Journal of Oncology.
Crossref
Crossref
David Martínez-García, Marta Pérez-Hernández, Luís Korrodi-Gregório, Roberto Quesada, Ricard Ramos, Núria Baixeras, Ricardo Pérez-Tomás & Vanessa Soto-Cerrato. (2019) The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models. Biomolecules 9:8, pages 361.
Crossref
Crossref
Cristina Trejo-Solís, Norma Serrano-Garcia, Ángel Escamilla-Ramírez, Rosa Castillo-Rodríguez, Dolores Jimenez-Farfan, Guadalupe Palencia, Minerva Calvillo, Mayra Alvarez-Lemus, Athenea Flores-Nájera, Arturo Cruz-Salgado & Julio Sotelo. (2018) Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma. International Journal of Molecular Sciences 19:12, pages 3773.
Crossref
Crossref
Baisen Li, Xiuhui Gu, Mingbo Wu, Ye Zhao, Jie Yang, Li Feng, Junjie Gou, Linyi Chen, Ting Li, Linpeng Li, Lan Wang, Li Zhu & Kun Zhang. (2018) Plumbagin inhibits the proliferation of nasopharyngeal carcinoma 6-10B cells by upregulation of reactive oxygen species. Anti-Cancer Drugs 29:9, pages 890-897.
Crossref
Crossref
Fanglong Wu, Xueke Shi, Rui Zhang, Yuan Tian, Xiangjian Wang, Changlei Wei, Duo Li, Xiaoyu Li, Xiangli Kong, Yurong Liu, Weihua Guo, Yiqing Guo & Hongmei Zhou. (2018) Regulation of proliferation and cell cycle by protein regulator of cytokinesis 1 in oral squamous cell carcinoma. Cell Death & Disease 9:5.
Crossref
Crossref
Hui Guo, Shan Kuang, Qiao-ling Song, Man Liu, Xiao-xiao Sun & Qiang Yu. (2017) Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments. Acta Pharmacologica Sinica 39:3, pages 425-437.
Crossref
Crossref
Xueqiang Zhu, Hui Huang, Jun Zhang, Hao Liu, Rui Ao, Ming Xiao & Yuelei Wu. (2017) The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway. Molecular Medicine Reports.
Crossref
Crossref
Bassem Y. Sheikh, Md. Moklesur Rahman Sarker, Muhamad Noor Alfarizal Kamarudin & Amin Ismail. (2017) Prophetic medicine as potential functional food elements in the intervention of cancer: A review. Biomedicine & Pharmacotherapy 95, pages 614-648.
Crossref
Crossref
Anqun Tang, Keyu Gao, Laili Chu, Rui Zhang, Jing Yang & Junnian Zheng. (2017) Aurora kinases: novel therapy targets in cancers. Oncotarget 8:14, pages 23937-23954.
Crossref
Crossref
Tai Yang, Jin Liu, Mali Yang, Ning Huang, Yueling Zhong, Ting Zeng, Rong Wei, Zhongjun Wu, Cui Xiao, Xiaohua Cao, Minhui Li, Limei Li, Bin Han, Xiaoping Yu, Hua Li & Qiang Zou. (2016)
Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells
in vitro
and
in vivo
by modulating multiple cellular pathways
. Oncotarget 8:4, pages 5800-5813.
Crossref
Crossref
Shenlu Qin, Xumeng Wang, Huanwen Wu, Peng Xiao, Hongqiang Cheng, Xue Zhang & Yuehai Ke. (2016) Cell-based phenotypic screening of mast cell degranulation unveils kinetic perturbations of agents targeting phosphorylation. Scientific Reports 6:1.
Crossref
Crossref
E. P. Jane, D. R. Premkumar, J. M. Cavaleri, P. A. Sutera, T. Rajasekar & I. F. Pollack. (2015) Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines. Journal of Pharmacology and Experimental Therapeutics 356:2, pages 354-365.
Crossref
Crossref
Omar Nunez Lopez, Fredrick J. Bohanon, Xiaofu Wang, Na Ye, Tiziana Corsello, Yesenia Rojas-Khalil, Haijun Chen, Haiying Chen, Jia Zhou & Ravi S. Radhakrishnan. (2016) STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis. RSC Advances 6:102, pages 100652-100663.
Crossref
Crossref